Antibiotic Susceptibility Profiles of Bacteria from Diabetic Foot Infections in Selected Teaching Hospitals in Southwestern Nigeria

Olorunjuwon O Bello; Edward O Oyekanmi; Babatunde A Kelly; Olakunle O Mebude; Temitope K Bello

doi:10.21467/ias.4.1.1-13

Authors

Olorunjuwon O Bello Department of Biological Sciences, College of Natural and Applied Sciences, Wesley University Ondo
Edward O Oyekanmi Department of Biological Sciences, College of Natural and Applied Sciences
Babatunde A Kelly Department of Biological Sciences, College of Natural and Applied Sciences, Wesley University Ondo
Olakunle O Mebude Department of Biological Sciences, College of Natural and Applied Sciences, Wesley University Ondo
Temitope K Bello Department of Biological Sciences, Faculty of Pure and Applied Sciences

DOI:

https://doi.org/10.21467/ias.4.1.1-13

Abstract

One of the serious complications associated with diabetes is foot ulcer and this condition affects the quality of life in patients in all classes, races and ages. Chronic wounds are prone to colonization by wide array of microorganisms which could be extremely hazardous to patients if effective and timely therapeutic intervention is not made. This study was conducted to determine the antibiotic susceptibility profiles of bacteria from diabetic foot infections in southwestern Nigeria. Samples were collected from a total of 142 diabetic foot ulcer patients with moistened sterile cotton swabs. Nutrient agar, Mac-Conkey agar, blood agar and mannitol salt agar media were used for the isolation of total viable bacteria, Gram-negative non-spore forming lactose fermenters, fastidious bacteria and staphylococci, respectively. Morphological and biochemical characteristics of pure cultures were determined in accordance with standard laboratory criteria. API 20 E and API 20 NE were used for the confirmation of identity of the bacterial isolates. The disc diffusion technique was employed for the determination of antibiotic susceptibility of bacterial isolates in accordance with standard procedures. The antibiotics investigated included amikacin, amoxicillin, ampicillin, ceftazidime, cefazolin, ceftriaxone, chloramphenicol, ciprofloxacin, clindamycin, gentamicin, imipenem, linezolid, methicillin, netilmicin, ofloxacin, oxacillin, penicillin, piperacilin, sulfamethoxazole, trimethoprim and vancomycin. One hundred and seventy-seven isolates were encountered and these were characterized into eleven bacterial species. These included Staphylococcus aureus (22.03%), Pseudomonas aeruginosa (16.95%), Staphylococcus epidermidis (12.43%), Proteus mirabilis (8.48%), Klebsiella pneumoniae (7.91%), E. coli (7.35%), Staphylococcus saprophyticus (6.78%), Streptococcus pyogenes (5.65%), Morganella morganii (5.09%), Citrobacter freundii (4.52%) and Acinetobacter baumannii (2.83%). Gram-negative bacteria showed 76.99% susceptibility to the antibiotics while 22.85% was resistant. Gram-positive bacteria showed 93.75% susceptibility and 5.01% resistance to the antibiotics. This study revealed that there is no definite aetiologic bacterial agent for diabetic foot infections and many of the associated bacteria are sensitive to certain antibiotics.

Keywords:

Antibiotics, bacteria, diabetes, foot ulcer, infections, resistance, susceptibility

Downloads

Download data is not yet available.

References

J. Jneida, J.P. Lavigneb, B. La Scolaa and N. Cassira, ‘The diabetic foot microbiota: A review,” Human Microbiome Journal, vol. 5–6, pp. 1-6, Dec. 2017.

World Health Organization [WHO], Global Report on Diabetes. Geneva: April 2016.

N. R. Barshes, M. Sigireddi, J. S. Wrobel, A. Mahankhali, J. L. Robbins, P. Kougias and D. G. Armstrong, “The system of care for the diabetic foot: objectives, outcomes and opportunities,” Diabetic Foot and Ankle vol. 4, p. 21847. Oct. 2013.

R. E. Mirza, M. M. Fang, E. M. Weinheimer-Haus, W. J. Ennis and T. J. Koh, “Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice,” Diabetes, vol. 63, no. 3, pp. 1103–1114, March 2014.

E. C. Leal, E. Carvalho, A. Tellechea, A. Kafanas, F. Tecilazich, C. Kearney, S. Kuchibhotla, M. E. Auster, E. Kokkotou, D. J. Mooney, F. W. LoGerfo, L. Pradhan-Nabzdyk and A. Veves, “Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype,” The American Journal of Pathology, vol. 185, no. 6, pp. 1638–1648, June 2015.

I. Hsu, L. G. Parkinson, Y. Shen, A. Toro, T. Brown, H. Zhao, R.C. Bleackley and D. J. Granvile, “Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing,” Cell Death and Disease, vol. 5, e1458, Oct 2014.

A. Spichler, B. L. Hurwitz, D. G. Armstrong and B. A. Lipsky, “Microbiology of diabetic foot infections: from Louis Pasteur to ‘crime scene investigation,’” BMC Medicine. vol. 13, p. 2, Jan. 2015.

J. Moura, J. Rodrigues, M. Goncalves, C. Amaral, M. Lima and E. Carvalho, “Impaired T-cell differentiation in diabetic foot ulceration,” Cellular and Molecular Immunology, vol. 14, pp. 758–769, March 2016.

R. D. Wolcott, J. D. Hanson, E. J. Rees, L. D. Koenig, C. D. Phillips, R. A. Wolcott, S. B. Cox and J.S. White, “Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing,” Wound Repair Regen, vol. 24, no. 1, pp. 163–174, Feb 2016.

K. Rahim, S. Saleha, X. Zhu, L. Huo, A. Basit, and O. L. Franco, “Bacterial Contribution in Chronicity of Wounds,” Microbial Ecology, vol. 73, no. 3, pp. 710–721, April 2017.

R.E. Pecoraro, G.E. Reiber, E.M. Burgess. “Pathways to diabetic limb amputation: basis for prevention,” Diabetes Care, vol. 13, no. 5, pp. 513-521, May 1990.

B.A. Lipsky, A.R. Berendt, P.B. Cornia, J.C. Pile, E.J.G. Peters, D.G. Armstrong, H.G., Deery, J.M. Embil, W.S. Joseph, A.W. Karchmer, M.S. Pinzur and E. Senneville. “2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections,” Clinical Infectious Diseases, vol. 54, no. 12, e132 - e173, June. 2012.

A. Icks, M. Scheer, E. Morbach, J. Genz, B. Haastert, G. Giani, G. Glaeske and F. Hoffman, “Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation.” Diabetes Care, vol. 34, pp. 1350–1354, June 2011.

M. Kerr, “Foot Care for People with Diabetes: The Economic Case for Change,” NHS Diabetes, 2012-03. Available at: http://www.diabetes.org.uk/Documents/nhs-diabetes/footcare/footcare-for-people-with-diabetes.pdf [accessed July 19,2017].

A. Banu, M. M. NoorulHassan, J. Rajkumar, and S. Srinivasa, “Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: a prospective study,” The Australasian Medical Journal, vol. 8, no. 9, pp. 280–285, Sept 2015.

R. Santos, A.S. Veiga, L. Tavares, M. Castanho and M. Oliveira, “Bacterial biofilms in diabetic foot ulcers: potential alternative therapeutics”, in Microbial Biofilms – Importance and Applications, ed. D. Dhanasekaran and N. Thajuddin (Rijeka: InTech Press), July 2016. pp. 251–269.

M. Cheesbrough. District laboratory practice in tropical countries. part 2, 2nd ed. UK: Cambridge University, 2006, p. 35–197.

CLSI (Clinical Laboratory Standards Institute), “Performance standards for antimicrobial susceptibility testing” NCCLS approved standard M100-S14, Wayne, PA. USA, II (2), 2016, pp. 298-102.

M. C. Perim, J. C. Borges, S. R. C. Celeste, E. F. Orsolin, R. R. Mendes, G. O. Mendes, R. L. Ferreira, S.C. Carreiro, and M.C. Pranchevicius, “Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 48, no. 5, Sept/Oct 2015.

A. Nageen, “The Most Prevalent Organism in Diabetic Foot Ulcers and Its Drug Sensitivity and Resistance to Different Standard Antibiotics,” Journal of the College of Physicians and Surgeons Pakistan, vol. 26, no. 4, pp. 293-296, Dec 2016.

M. S. S. Pradeep, K. Vishnuvardhanarao and C. R. Setty, “Bacteriological profile and their Antibiotic Sensitivity Pattern in Diabetic Foot Infections in a Tertiary Care Hospital,” Scholars Journal of Applied Medical Sciences, vol. 5, no. 5C, pp. 1883-1887, May 2017.

G.S. Banashankari, H.K. Rudresh and A.H. Harsha. “Prevalence of Gram Negative Bacteria in Diabetic Foot-A Clinico-Microbiological Study,” Al-Ameen Journal of Medical Sciences, vol. 5, no. 3, pp. 224 -232, Sept. 2012.

S.J.C. Daniel, E. Gowthami and S. Sowmiya, “Isolation and identification of bacterial pathogens from wounds of diabetic patients,” International Journal of Current Microbiology and Applied Sciences, vol. 2, no. 11, pp. 72-77, 2013.

Z. Mohammad, M. Abida and A. Jamal. “Clinico-bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India.” Biology and Medicine, vol. 2, no. 4, pp. 22-34, 2010.

K. Joseph, A. T. George, M. B. Divya and K. K. Ameena, “Diabetic foot infections: characterization and antibiotic resistance pattern of aerobic bacterial isolates in a tertiary care hospital of North Kerala.” International Journal of Current Microbiology and Applied Sciences, vol. 6, no. 9, pp. 3493-3499, Sept 2017.

A. Oates, L. Frank, J.M.B. Andrew, M. Boulton -Citron, J. Ellie, C. Goldstein, C. Vreni- Merriam, A.B. Lipsky and A. Murray. “Bacteriology of moderate-to-severe diabetic foot infections and In vitro activity of antimicrobial agents,” Journal of Clinical Microbiology, vol. 45, no. 9, pp. 2819-2828, July 2007.

M. Anvarinejad, G. Pouladfar, A. Japoni, S. Bolandparvaz, Z. Satiary and J. Mardaneh, “Diabetic Foot Infections: antibiotic susceptibility patterns and determination of antibiotic cross-resistance in clinical isolates of Enterococcus species during 2012 - 2014 in Shiraz, Iran,” Arch Pediatr Infect Dis., vol. 5, no. 2, e37680, April 2017.

E. J. Peters, B. A. Lipsky, J. Aragon-Sanchez, E. J. Boyko, M. Diggle, J. M. Embil, S. Kono, L. A. Lavery, E. Senneville, V. Urbancic-Rovan, S. A. Van Asten and W. J. Jeffocate, “Interventions in the management of infection in the foot in diabetes: a systematic review.” Diabetes Metabolism Research and Review, vol. 32, no. 1, pp. 145–53, Jan 2016.

M. T. Akhi, R. Ghotaslou, M. Asgharzadeh, M. Varshochi, T. Pirzadeh, M. Y. Memar, A. Z. Bialvaei, H. S. Y. Sofla and N. Alizadeh “Bacterial etiology and antibiotic susceptibility pattern of diabetic foot infections in Tabriz, Iran,” GMS Hygiene and Infection Control, vol. 10, no. 2, Feb 2015.

T. G. D. Pemayun, and R. M. Naibaho, “Clinical profile and outcome of diabetic foot ulcer, a view from tertiary care hospital in Semarang, Indonesia.” Diabetic Foot and Ankle, vol. 8, no. 1, p. 1312974, May 2017.

S. V. Patil and R. R. Mane. Bacterial and clinical profile of diabetic foot ulcer using optimal culture techniques. International Journal of Research in Medical Sciences, vol. 5, no. 2, pp. 496-502, Feb 2017.

A. Karakus, M. Ozkan, M. Karcioglu, R. Ozden, I. Ustun, K. Caliskan, C. Gokce and M. Sahan, “Diabetic foot due to anaphylactic shock: a case report.” Archives of Trauma Research, vol. 3, no. 2, e17610, June 2014.

B. Poorabbas, J. Mardaneh, Z. Rezaei, M. Kalani, G. Pouladfar, M. H. Alami, J. Soltani, A. Shamsi-Zadeh, S. Abdoli-Oskooi, M. J. Saffar and A. Alborzi, “Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran.” Iranian Journal of Microbiology, vol. 7, no. 3, pp. 127–35, June 2015.

T. Semedo-Lemsaddek, C. Mottola, C. Alves-Barroco, P. Cavaco-Silva, L. Tavares, M. Oliveira, “Characterization of multidrug-resistant diabetic foot ulcer enterococci.” Enfermedades Infecciosas y Microbiologia Clinica, vol. 34, no. 2, pp. 114–116, Feb 2015.

J. Mardaneh, and M. M. Soltan-Dallal, “Isolation and identification of E. cowanii from powdered infant formula in NICU and determination of antimicrobial susceptibility of isolates. Iranian Journal of Pediatrics, vol. 24, no. 3, pp. 261–266, June 2014.

J. Soltani, B. Poorabbas, N. Miri, and J. Mardaneh, “Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran.” World Journal of Clinical Cases, vol. 4, no. 3, pp. 63–70, March 2016.

O.O. Bello, H.O. Egberongbe, T.O. Adesetan and A.M. Adenekan, “Antibiotic sensitivity profiles of bacteria isolated from decayed teeth,” Scholars Academic Journal of Pharmacy, vol. 2, no. 6, pp. 424-428, Nov 2013.

S. Chang, D.M. Sievert, J.C. Hageman, M.L. Boulton, F.C. Tenover, F.P. Downes, S. Shah, J.T. Rudrik, G.R. Pupp, W.J. Brown, D. Cardo and S.K. Fridkin. “Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.” New England Journal of Medicine, vol. 348, no. 14, pp. 1342 1347, Apr. 2003.

A. F. de Oliveira and H. D. Oliveira Filho, “Microbiological species and antimicrobial resistance profile in patients with diabetic foot infections,” Jornal Vascular Brasileiro, vol. 13, no. 4, pp. 289–293, Dec 2014.

M.F.P. Raymundo, and M.T. Mendoza, “The microbiological features and clinical outcome of diabetic foot infections among patients admitted at UP-PGH.” Phillipines Journal of Microbiology and Infectious Diseases, vol. 31, pp. 51-63, 2002.

N. Singh, D.G. Armstrong and B.A. Lipsky, “Preventing foot ulcers in patients with diabetes.” The Journal of the American Medical Association, vol. 293, no. 2, pp. 217-28, Jan. 2005.

W.J. Jeffcoate, B.A. Lipsky, A.R. Berendt, P.R. Cavanagh, S.A. Bus, E.J. Peters, W.H. van Houtum, G.D. Valk and K. Bakker, “Unresolved issues in the management of ulcers of the foot in diabetes.” Diabetic Medicine, vol. 25, vol. 12, pp.1380-1389, Jan 2009.

B. M. Pabithadevi, V. K. Rajendran and M. Sadana, “Clinical Outcomes of Diabetic Foot and Its Management,” IOSR Journal of Dental and Medical Sciences, vol. 15, no. 1, pp. 10-15, Jan 2016.

X. Xie, Y. Bao, L. Ni, D. Liu, S. Niu, H. Lin, H. Li, C. Duan, L. Yan, S. Huang and Z. Luo, “Bacterial profile and antibiotic resistance in patients with diabetic foot ulcer in Guangzhou, Southern China: focus on the differences among different Wagner’s Grades, IDSA/IWGDF grades, and ulcer types. International Journal of Endocrinology, vol. 2017, Article ID 8694903, pp. 1 – 12, July 2017.